Loading...

PerkinElmer, Inc.

PKINYSE
Healthcare
Medical - Diagnostics & Research
$115.24
$-1.06(-0.91%)

PerkinElmer, Inc. (PKI) Stock Overview

Explore PerkinElmer, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.5/100

Key Financials

Market Cap14.5B
P/E Ratio47.02
EPS (TTM)$2.78
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$72.82

PKI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PerkinElmer, Inc. (PKI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $72.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 47.02 and a market capitalization of 14.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;